org placeholder image

Chunyan Gu

Director, Translational Science at Kartos Therapeutics

  • LinkedIn

Email Email: c****@corvuspharma.com

phone noPhone Number: (***)-***-****

map
KARTOS THERAPEUTICS

KARTOS THERAPEUTICS

  • description Description
    Kartos Therapeutics is a privately held, clinical-stage biopharmaceutical company developing a potentially best-in-class MDM2 inhibitor. Launched in 2018 by proven industry veterans, we are a...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 25 Million to 50 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Kartos Therapeutics Org Chart and Mapping

Employees

Amanda Cannon

Senior Director Regulatory Affairs

Jordan Blevins

Senior Clinical Trial Manager

Anna Nekhymchuk

Senior Clinical Trial Manager

Anna Harris

Senior Clinical Trial Manager

Sheryl Zausen

Sr. Director, Clinical Data Management

May Gallardo

Senior Director Finance

Chunyan Gu

Director, Translational Science

Frequently Asked Questions Regarding Chunyan Gu

Answer: Chunyan Gu works for Kartos Therapeutics as Director, Translational Science

Answer: Chunyan Gu’s role in Kartos Therapeutics is Director, Translational Science

Answer: Chunyan Gu's email address is c***@gmail.com

Answer: Chunyan Gu's business email address is c****@corvuspharma.com

Answer: Chunyan Gu’s direct phone number is (***)-***-****

Answer: Chunyan Gu works in the industry of: Biotechnology

Answer: Chunyan Gu works Kartos Therapeutics located at 275 Shoreline Dr, Redwood City, California, 94065, United States

Answer: Kartos Therapeutics's Director, Translational Science is Chunyan Gu

Answer: Chunyan Gu contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@corvuspharma.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access